ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for discussion Regístrate para interactuar en nuestros foros activos para discutir con inversores de ideas afines.
Roquefort Therapeutics Plc

Roquefort Therapeutics Plc (ROQ)

4.18
-0.02
(-0.48%)
Cerrado 04 Enero 10:30AM

Su centro para precios en tiempo real, ideas y debates en vivo

Estadísticas y detalles clave

Último Precio
4.18
Postura de Compra
3.80
Postura de Venta
4.10
Volume Operado de la Acción
848,155
3.95 Rango del Día 4.25
3.35 Rango de 52 semanas 9.25
Capitalización de Mercado [m]
Precio Anterior
4.20
Precio de Apertura
4.20
Última hora de negociación
Volumen financiero
35,453p
Precio Promedio Ponderado
4.18
Volumen promedio (3 m)
1,522,780
Acciones en circulación
129,149,998
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-2.93
Beneficio por acción (BPA)
-0.01
turnover
200k
Beneficio neto
-1.75M

Acerca de Roquefort Therapeutics Plc

Sector
Cmp Integrated Sys Design
Industria
Cmp Integrated Sys Design
Sede
London, Gbr
Fundado
-
Roquefort Therapeutics Plc is listed in the Cmp Integrated Sys Design sector of the London Stock Exchange with ticker ROQ. The last closing price for Roquefort Therapeutics was 4.20p. Over the last year, Roquefort Therapeutics shares have traded in a share price range of 3.35p to 9.25p.

Roquefort Therapeutics currently has 129,149,998 shares in issue. The market capitalisation of Roquefort Therapeutics is £5.42 million. Roquefort Therapeutics has a price to earnings ratio (PE ratio) of -2.93.

ROQ Últimas noticias

Roquefort Therapeutics proposes USD10 million subsidiary sale

Roquefort Therapeutics PLC on Thursday said it has proposed the sale of subsidiary Lyramid Pty Ltd to Pleiades Pharma ...

Roquefort Therapeutics PLC Proposed Sale of Midkine Portfolio

Roquefort Therapeutics PLC 02 January 2025   2 January 2025 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") Proposed Sale of Midkine Portfolio   Roquefort Therapeutics...

Roquefort Therapeutics PLC Director Share Distribution

Roquefort Therapeutics PLC 04 December 2024   4 December 2024   Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company")   Director Share Distribution   Roquefort Therapeutics...

Roquefort Therapeutics PLC Conversion of Convertible Loan Notes

Roquefort Therapeutics PLC 07 November 2024   7 November 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company") Conversion of Convertible Loan Notes   Roquefort...

EARNINGS: Kendrick Resources loss narrows; Emmerson CFO to depart

The following is a round-up of earnings for London-listed companies, issued on Friday and not separately reported by ...

Roquefort Therapeutics PLC Interim Results to 30 June 2024

Roquefort Therapeutics PLC 27 September 2024   27 September 2024 Roquefort Therapeutics plc ("Roquefort Therapeutics" or the "Company")   Interim Results to 30 June 2024   Roquefort...

Roquefort Therapeutics says MK cell therapy patent approved in Japan

Roquefort Therapeutics PLC on Monday announced its patent for mesodermal killer, or MK, cell therapy has been approve ...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10.133.209876543214.0553.915516344.13536455DE
40.030.7228915662654.1553.810208524.19371313DE
120.235.822784810133.956.753.615227804.64191828DE
26-0.57-124.756.753.358335424.53380493DE
52-3.07-42.34482758627.259.253.355612554.75810797DE
156-6.32-60.190476190510.511.253.353689336.43966031DE
260-1.82-30.3333333333613.53.353026316.55085003DE

ROQ - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Roquefort Therapeutics?
El precio actual de las acciones de Roquefort Therapeutics es 4.18p
¿Cuántas acciones de Roquefort Therapeutics están en circulación?
Roquefort Therapeutics tiene 129,149,998 acciones en circulación
¿Cuál es la capitalización de mercado de Roquefort Therapeutics?
La capitalización de mercado de Roquefort Therapeutics es GBP 5.42M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Roquefort Therapeutics?
Roquefort Therapeutics ha negociado en un rango de 3.35p a 9.25p durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Roquefort Therapeutics?
El ratio precio/beneficio de Roquefort Therapeutics es -2.93
¿Cuál es el ratio de efectivo a ventas de Roquefort Therapeutics?
El ratio de efectivo a ventas de Roquefort Therapeutics es 26.33
¿Cuál es la moneda de reporte de Roquefort Therapeutics?
Roquefort Therapeutics presenta sus resultados financieros en GBP
¿Cuál es el último ingresos anual de Roquefort Therapeutics?
El último ingresos anual de Roquefort Therapeutics es GBP 200k
¿Cuál es el último beneficio anual de Roquefort Therapeutics?
El último beneficio anual de Roquefort Therapeutics es GBP -1.75M
¿Cuál es la dirección registrada de Roquefort Therapeutics?
La dirección registrada de Roquefort Therapeutics es 85 GREAT PORTLAND STREET, FIRST FLOOR, LONDON, W1W 7LT
¿Cuál es la dirección del sitio web de Roquefort Therapeutics?
La dirección del sitio web de Roquefort Therapeutics es www.roquefortplc.com
¿En qué sector industrial opera Roquefort Therapeutics?
Roquefort Therapeutics opera en el sector CMP INTEGRATED SYS DESIGN

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
TCFTheracryf Plc
0.725p
(38.10%)
7.56M
NMTNeometals Ltd
3.50p
(27.27%)
346.81k
SCHOScholium Group Plc
44.00p
(25.71%)
30.65k
FABFusion Antibodies Plc
10.15p
(24.54%)
3.34M
PYXPyx Resources Limited
3.49p
(22.24%)
8.43k
TM1Technology Minerals Plc
0.125p
(-24.24%)
37.21M
QUIZQuiz Plc
0.70p
(-18.60%)
3.67M
SYMESupply@me Capital Plc
0.003p
(-17.81%)
168.35M
OBDOxford Biodynamics Plc
1.20p
(-14.29%)
827.83k
ZENZenith Energy Ltd.
5.25p
(-13.93%)
5.39M
TRPTower Resources Plc
0.0395p
(5.33%)
539.51M
CPXCap-xx Limited
0.1825p
(1.39%)
494M
NTVONativo Resources Plc
0.0019p
(0.00%)
320.16M
DGIDg Innovate Plc
0.0225p
(-13.46%)
208.21M
ENETEthernity Networks Ltd
0.1125p
(2.27%)
207.56M
Myth Myth 4 minutos hace
Good afternoon Cap. what's the word ??
Myth Myth 5 minutos hace
Grace Potter "Paris/Ooh La La" (Live)

https://www.youtube.com/watch?v=lWltKLNvg-I
cjstocksup cjstocksup 5 minutos hace
Is another Biden blanket pardon next?
https://x.com/RealJamesWoods/status/1874941082959860155
capgain capgain 5 minutos hace
Good afternoon.
JTORENCE JTORENCE 6 minutos hace
alphapuppy You are being sarcastic right?
NWBO
martyDg martyDg 6 minutos hace
Are you giving the longs investment advice about what the longs should do after the approval? Are you being funny? You're the one trying to give an investment advice here.

This is the one I said.
it's your money do whatever you like with it. But, don't represent for everyone th
NWBO
cjstocksup cjstocksup 6 minutos hace
It isn’t the guns. We all know what the problem is.
https://x.com/RealJamesWoods/status/1875255864321577325
Shawonsarker84 Shawonsarker84 7 minutos hace
Love it familyof5! Most honest and genuine opinion 👌
HMBL
Monksdream Monksdream 8 minutos hace
The chart looks bearish
https://investorshub.advfn.com/uimage/uploads/2025/1/4/xvienIMG_4443.gif
doc2016 doc2016 9 minutos hace
the below is my understanding/memory of the public information whichi rely upon for these thoughts:
ionq and nvidia working together. separately, ionq and nvidia are partnered with astrazeneca, which is partnered with novartis.
novartis linked board member on 8 board of directors.
IONQ
blackhawks blackhawks 10 minutos hace
Most people old enough to remember when South Africa was described as that kind of state know the meaning.

People too young for that SHOULD clue it out from 'apart' registering before 'theid' kicks in, and from context.
cjstocksup cjstocksup 10 minutos hace
That Johnson finally makes it on the first ballot is important. It says that the Trump Agenda of America First is now on turbo boost with a cohesive House, Senate, Supreme Court and President.

We can’t afford to let the Democrats who’ve destroyed this country in the last four years e
familyof5 familyof5 10 minutos hace
NoMoDo do I have your consent to re-post?

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175618147


....if not I will request deletion.
HMBL
Konaploinks Konaploinks 10 minutos hace
Shawn yep. And IonQ has the patent on photonic linkage and daisy chaining along with over 600 other patents . I wouldn’t be surprised if Jensen mentioned IonQ . They presented together at SC 24 in Atlanta So why not? I see a j v being announced then later a buyout imo. He’d be King Jensen with thos
NVDA
newmedman newmedman 11 minutos hace
did you watch the video? I don't know about you but that scene has always been etched in my mind ever since I saw the "barnyard babes" VHS tape back in the 90's.

It didn't involve mayonnaise if you know what I mean and I remain forever scarred by it.
Poo28 Poo28 11 minutos hace
WHO CARES what a staffer with no authority and no decision making role thinks on a matter totally Dismissed. The Commission took no notice of a low level cherry picked opinion sought by Enforcement from 2018. Motion Denied.

Read my earlier response , no one cared, Motion Denied, and
DBMM
DewDiligence DewDiligence 11 minutos hace
CAT’s reciprocating-engine business is a play on this:

#msg-174689607
JSmith5 JSmith5 11 minutos hace
Thanks Ace Trader - Can't disagree with what you said but do want to clarify the following:

Gov gets 7 trillion in housing debt off the books

Technically, it's not on the books. It may be in a cookie jar somewhere or under Biden's mattress (it's OK - he would not be aw
FNMA
NEnorth NEnorth 11 minutos hace
I guess the way I'm seeing things now is something has to happen good or bad as there is way to much money involved to stay stagnant much longer Wouldn't you agree ??
CBRF
Paulie Pennies Paulie Pennies 12 minutos hace
Year end numbers should put us at about $45 million in revs😎
ASII
x993231 x993231 12 minutos hace
2025 will be an interesting year with Paul Atkins incharge of the SEC moving them away from the current focus on ESG, he is not a fan of  naked shorts, oh and rule 13-f 2 with form Sho will also shine a new light on short selling across the industry. Went into effect a few days ago.

X
LWLG
Ftor Ftor 12 minutos hace
Hi,

I have few questions on the FNMA / FMCC latest activity. I own common shares.

1) What would happen to the common shares that are we already own which are being traded around $4.5 as of today once they are released from the conservatorship?

2) What doe
FMCC
firebag1 firebag1 13 minutos hace
Moniker
HMBL

Su Consulta Reciente

Delayed Upgrade Clock